Clinical Trials Insight: 700033952
Phase of Trial: Phase III
Latest Information Update: 07 Apr 2010
At a glance
- Drugs Testosterone (Primary)
- Indications Decreased libido; Menopause
- Focus Adverse reactions; Registrational
- Sponsors Acrux
- 07 Apr 2010 Company association changed from VIVUS to Acrux.
- 27 May 2008 New trial record.